治疗新靶点

2.2 活化的RET和ROS:肺腺癌中的两个新的驱动突变

Published at: 2014年第1卷第11期

Marc Bos 1 , Masyar Gardizi 2 , Hans-Ulrich Schidhaus 2 , Reinhard Buettner 2 , Juergen Wolf 3
1 Department I of Internal Medicine, University Hospital Cologne; Center for Integrated Oncology Cologne/Bonn, Germany
2 Center for Integrated Oncology Cologne/Bonn; Institute of Pathology, University Hospital Cologne, Cologne, Germany
3 Dep. I of Internal Medicine, University Hospital Cologne, Kerpener Straße 62, D-50937 Köln, Germany
关键词: 肺癌 腺癌 RET ROS
请购买后进行阅读
comments powered by Disqus